Rodriguez-Perez, Ana I <br/><br/>
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death.  [electronic resource] 

 -  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics  10 2018 
 - 1063-1081 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-7479 
<br/><br/><label>Standard No.: </label>10.1007/s13311-018-0646-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Animals<br/>Benzimidazoles--therapeutic use<br/>Biphenyl Compounds<br/>Calcium-Binding Proteins--metabolism<br/>Cell Death--drug effects<br/>Cytokines--metabolism<br/>Dependovirus--genetics<br/>Disease Models, Animal<br/>Dopaminergic Neurons--drug effects<br/>Encephalitis--chemically induced<br/>Glial Fibrillary Acidic Protein--metabolism<br/>Green Fluorescent Proteins--genetics<br/>Humans<br/>Male<br/>Microfilament Proteins--metabolism<br/>Microscopy, Confocal<br/>Mutation--genetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Synapsins--genetics<br/>Telmisartan--therapeutic use<br/>Tetrazoles--therapeutic use<br/>Transduction, Genetic<br/>Tyrosine 3-Monooxygenase--metabolism<br/>alpha-Synuclein--toxicity